Platelet-derived growth factor is a cofactor in the induction of 1α(I) procollagen expression by transforming growth factor-β1 in smooth muscle cells

B. G. Halloran, B. J. So, Bernard Timothy Baxter, G. A. Sicard, D. Brenin

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose: Depending on the derivation of vascular smooth muscle cells (SMC), transforming growth factor-β1 (TGF-β1) has variable effects on proliferation and expression of extracellular matrix. Relatively little is known about TGF-β1's effects on human arterial SMC. Therefore, we sought to determine the effects of TGF-β1 on human arterial SMC proliferation and 1α(I) procollagen expression. The mechanisms by which TGF-β1 regulate type I procollagen expression were also investigated. Methods: SMC cultures were established from the aorta of transplant donors. Serial doses of TGF-β1 were applied, and cellular proliferation assessed by cell counting and tritiated thymidine incorporation. Total cellular ribonucleic acid (RNA) was analyzed by reverse transcription-polymerase chain reaction and Northern blot for changes in 1α(I) procollagen and platelet-derived growth factor (PDGF)-A transcripts. Results: In a dose-dependent manner, TGF-β1 inhibited SMC proliferation despite early induction of PDGF-A mRNA. After a delay of 24 hours, TGF-β1 increased 1α(I) procollagen expression by 36% compared with control. PDGF-neutralizing antibodies blocked the TGF-β1-mediated upregulation of type I procollagen, although PDGF alone had no effect on matrix expression. Conclusion: The results indicate that TGF-β1 is a potent inhibitor of human arterial SMC proliferation that has a moderate effect on 1α(I) procollagen transcripts. Despite inducing PDGF-A gene expressions TGF- β1 is not a mitogen in adult human arterial SMC. TGF-β1 regulates SMC type I procollagen expression partly by inducing PDGF-A as a co-factor.

Original languageEnglish (US)
Pages (from-to)767-774
Number of pages8
JournalJournal of vascular surgery
Volume23
Issue number5
DOIs
StatePublished - Jan 1 1996

Fingerprint

Procollagen
Platelet-Derived Growth Factor
Transforming Growth Factors
Smooth Muscle Myocytes
Collagen Type I
Cell Proliferation
Neutralizing Antibodies
Vascular Smooth Muscle
Mitogens
Northern Blotting
Thymidine
Reverse Transcription
Extracellular Matrix
Aorta
Up-Regulation
Cell Culture Techniques
Tissue Donors
RNA
Gene Expression

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Platelet-derived growth factor is a cofactor in the induction of 1α(I) procollagen expression by transforming growth factor-β1 in smooth muscle cells. / Halloran, B. G.; So, B. J.; Baxter, Bernard Timothy; Sicard, G. A.; Brenin, D.

In: Journal of vascular surgery, Vol. 23, No. 5, 01.01.1996, p. 767-774.

Research output: Contribution to journalArticle

@article{4a88301459aa4b8dae0b0e04b703a016,
title = "Platelet-derived growth factor is a cofactor in the induction of 1α(I) procollagen expression by transforming growth factor-β1 in smooth muscle cells",
abstract = "Purpose: Depending on the derivation of vascular smooth muscle cells (SMC), transforming growth factor-β1 (TGF-β1) has variable effects on proliferation and expression of extracellular matrix. Relatively little is known about TGF-β1's effects on human arterial SMC. Therefore, we sought to determine the effects of TGF-β1 on human arterial SMC proliferation and 1α(I) procollagen expression. The mechanisms by which TGF-β1 regulate type I procollagen expression were also investigated. Methods: SMC cultures were established from the aorta of transplant donors. Serial doses of TGF-β1 were applied, and cellular proliferation assessed by cell counting and tritiated thymidine incorporation. Total cellular ribonucleic acid (RNA) was analyzed by reverse transcription-polymerase chain reaction and Northern blot for changes in 1α(I) procollagen and platelet-derived growth factor (PDGF)-A transcripts. Results: In a dose-dependent manner, TGF-β1 inhibited SMC proliferation despite early induction of PDGF-A mRNA. After a delay of 24 hours, TGF-β1 increased 1α(I) procollagen expression by 36{\%} compared with control. PDGF-neutralizing antibodies blocked the TGF-β1-mediated upregulation of type I procollagen, although PDGF alone had no effect on matrix expression. Conclusion: The results indicate that TGF-β1 is a potent inhibitor of human arterial SMC proliferation that has a moderate effect on 1α(I) procollagen transcripts. Despite inducing PDGF-A gene expressions TGF- β1 is not a mitogen in adult human arterial SMC. TGF-β1 regulates SMC type I procollagen expression partly by inducing PDGF-A as a co-factor.",
author = "Halloran, {B. G.} and So, {B. J.} and Baxter, {Bernard Timothy} and Sicard, {G. A.} and D. Brenin",
year = "1996",
month = "1",
day = "1",
doi = "10.1016/S0741-5214(96)70238-0",
language = "English (US)",
volume = "23",
pages = "767--774",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Platelet-derived growth factor is a cofactor in the induction of 1α(I) procollagen expression by transforming growth factor-β1 in smooth muscle cells

AU - Halloran, B. G.

AU - So, B. J.

AU - Baxter, Bernard Timothy

AU - Sicard, G. A.

AU - Brenin, D.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Purpose: Depending on the derivation of vascular smooth muscle cells (SMC), transforming growth factor-β1 (TGF-β1) has variable effects on proliferation and expression of extracellular matrix. Relatively little is known about TGF-β1's effects on human arterial SMC. Therefore, we sought to determine the effects of TGF-β1 on human arterial SMC proliferation and 1α(I) procollagen expression. The mechanisms by which TGF-β1 regulate type I procollagen expression were also investigated. Methods: SMC cultures were established from the aorta of transplant donors. Serial doses of TGF-β1 were applied, and cellular proliferation assessed by cell counting and tritiated thymidine incorporation. Total cellular ribonucleic acid (RNA) was analyzed by reverse transcription-polymerase chain reaction and Northern blot for changes in 1α(I) procollagen and platelet-derived growth factor (PDGF)-A transcripts. Results: In a dose-dependent manner, TGF-β1 inhibited SMC proliferation despite early induction of PDGF-A mRNA. After a delay of 24 hours, TGF-β1 increased 1α(I) procollagen expression by 36% compared with control. PDGF-neutralizing antibodies blocked the TGF-β1-mediated upregulation of type I procollagen, although PDGF alone had no effect on matrix expression. Conclusion: The results indicate that TGF-β1 is a potent inhibitor of human arterial SMC proliferation that has a moderate effect on 1α(I) procollagen transcripts. Despite inducing PDGF-A gene expressions TGF- β1 is not a mitogen in adult human arterial SMC. TGF-β1 regulates SMC type I procollagen expression partly by inducing PDGF-A as a co-factor.

AB - Purpose: Depending on the derivation of vascular smooth muscle cells (SMC), transforming growth factor-β1 (TGF-β1) has variable effects on proliferation and expression of extracellular matrix. Relatively little is known about TGF-β1's effects on human arterial SMC. Therefore, we sought to determine the effects of TGF-β1 on human arterial SMC proliferation and 1α(I) procollagen expression. The mechanisms by which TGF-β1 regulate type I procollagen expression were also investigated. Methods: SMC cultures were established from the aorta of transplant donors. Serial doses of TGF-β1 were applied, and cellular proliferation assessed by cell counting and tritiated thymidine incorporation. Total cellular ribonucleic acid (RNA) was analyzed by reverse transcription-polymerase chain reaction and Northern blot for changes in 1α(I) procollagen and platelet-derived growth factor (PDGF)-A transcripts. Results: In a dose-dependent manner, TGF-β1 inhibited SMC proliferation despite early induction of PDGF-A mRNA. After a delay of 24 hours, TGF-β1 increased 1α(I) procollagen expression by 36% compared with control. PDGF-neutralizing antibodies blocked the TGF-β1-mediated upregulation of type I procollagen, although PDGF alone had no effect on matrix expression. Conclusion: The results indicate that TGF-β1 is a potent inhibitor of human arterial SMC proliferation that has a moderate effect on 1α(I) procollagen transcripts. Despite inducing PDGF-A gene expressions TGF- β1 is not a mitogen in adult human arterial SMC. TGF-β1 regulates SMC type I procollagen expression partly by inducing PDGF-A as a co-factor.

UR - http://www.scopus.com/inward/record.url?scp=0029940370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029940370&partnerID=8YFLogxK

U2 - 10.1016/S0741-5214(96)70238-0

DO - 10.1016/S0741-5214(96)70238-0

M3 - Article

C2 - 8667497

AN - SCOPUS:0029940370

VL - 23

SP - 767

EP - 774

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 5

ER -